Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	293.06	53.42	13.59
Graham Fair Price	-35.44	7.12	11.03
PEG	-122.92	-0.47	-0.21
Price/Book	-0.13	1.15	1.15
Price/Cash Flow	inf	0.00	18.15
Prices/Earnings	139.38	27.47	11.47
Price/Sales	15.71	7.91	6.84
Price/FCF	inf	0.00	18.15
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	-21.35	0.53	0.67
Operating Margin	-95.14	0.01	0.30
ROA	-59.81	< 0.005	0.01
ROE	0.03	0.01	-58.28
ROIC	0.04	< 0.005	-95.16
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	-0.10	-0.14	27.69
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.24	-0.95	-305.71
EPS QOQ	-0.54	-0.58	-7.39
FCF QOQ	0.03	0.00	inf
Revenue QOQ	-0.14	-0.15	-7.37
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	117.58	89.40	-23.97
Days Sales Outstanding (DSO)	59.67	79.70	33.56
Inventory Turnover	0.77	1.01	31.52
Debt/Capitalization	< 0.005	< 0.005	-34.87
Quick Ratio	5.30	5.35	0.80
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	14.71	19.91	35.33
Cash	7.86	6.79	-13.68
Capex	-0.48	n.A.	n.A.
Free Cash Flow	0.93	n.A.	n.A.
Revenue	2.47	2.13	-13.73
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	6.21	5.96	-4.06
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-13.37	-36.00	-169.22
Naive Interpretation	Member

06 - Financial Health · Bad

Rating